Flavopiridol treatment of patients aged 70 or older with refractory or relapsed chronic lymphocytic leukemia is a feasible and active therapeutic approach

Older chronic lymphocytic leukemia patients have poor outcomes with standard treatments and are underrepresented in clinical trials. We retrospectively reviewed outcomes of refractory chronic lymphocytic leukemia patients in two age categories (≥70 and <70 years) treated with single-agent flavopi...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Stephens, Deborah M., Ruppert, Amy S., Blum, Kristie, Jones, Jeffrey, Flynn, Joseph M., Johnson, Amy J., Ji, Jia, Phelps, Mitch A., Grever, Michael R., Byrd, John C.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Ferrata Storti Foundation 2012
विषय:
Original Articles and Brief Reports
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3291598/
https://ncbi.nlm.nih.gov/pubmed/22271900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.047324
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन